GEJ ADENOCARCINOMA
Clinical trials for GEJ ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GEJ ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GEJ ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough cancers
Disease control Recruiting nowThis early-phase study tests whether a new drug called NRM-823 is safe and tolerable for people with advanced solid tumors that have not responded to other treatments. About 150 participants with cancers like lung, ovarian, or triple-negative breast cancer will receive NRM-823 al…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Normunity AccelCo, Inc. • Aim: Disease control
Last updated May 26, 2026 10:14 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control Recruiting nowThis study is testing whether adding a drug called fruquintinib to standard chemotherapy and trastuzumab can help control advanced HER2-positive stomach or gastroesophageal junction cancer. It is for people who have not had prior treatment for their metastatic disease. The goal i…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New drug targets tumors directly in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in about 144 people with advanced solid tumors (like pancreatic, stomach, or lung cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors to kill cancer cells while limiting…
Matched conditions: GEJ ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated May 06, 2026 16:03 UTC